Cephagenix
PrivateLast Round
Seed
Jan 15, 2025
Total Funding Raised
$9.27M
Company Overview
Cephagenix operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Seed round in January 2025.
Cephagenix is a drug discovery company that develops novel migraine treatments by identifying and developing selective inhibitors of the ATP-sensitive potassium channel subtype expressed in intracranial arteries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cephagenix Comparables
Compare Cephagenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Slate Medicines | 78% | |
| Vedana Therapeutics | 71% | |
| H. Lundbeck A/S | 67% |
For institutional investors. Book with your work email.
Cephagenix Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Cephagenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AbbVie Ventures | Seed |
| AdBio partners | Seed |
Cephagenix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cephagenix's valuation, stock price, and market status.
Is Cephagenix a public or private company?
Cephagenix is a private company.
What is the current stock price of Cephagenix?
Cephagenix is a private company, so its shares have no public market price. Caplight tracks Cephagenix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cephagenix worth (valuation)?
Valuation information for Cephagenix is not publicly available.
Can I buy Cephagenix stock?
Cephagenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cephagenix's last funding round?
Cephagenix's most recent funding round was Seed on January 15, 2025.
Who are the main investors in Cephagenix?
Key investors in Cephagenix include AbbVie Ventures, AdBio partners.
Will Cephagenix IPO soon?
No public IPO plans have been announced for Cephagenix.
How can I track Cephagenix secondary market activity?
Caplight tracks bids, offers, and trades in Cephagenix's shares on secondary markets.